Reports of confirmed transverse myelitis in Oxford COVID-19 trial 'incorrect'

The company behind the stage 3 clinical trials of the Oxford University COVID-19 vaccine candidate says reports that a participant has a confirmed case of transverse myelitis are "incorrect".